Back to search

National and Kapodistrian University of Athens

Γενωμική διερεύνηση μη ταυτοποιημένων μυοπαθειών

Abstract

dc:description

Introduction: Myopathies represent a heterogeneous group of neuromuscular disorders primarily affecting the skeletal muscle tissue. Hereditary myopathies are the most common, and present with more severe clinical features. Over 200 genes, including some of the largest ones in humans, have been implicated in myopathies. Prompt diagnosis may be challenging due to clinical heterogeneity and clinical overlaps, in addition to the large number and diversity of candidate genes and underlying mechanisms. Aim of the study: 1.The use of an NGS-based diagnostic approach to allow identification of causative variants, in muscle specific genes, for patients with a clinical presentation suggestive of myopathy. 2.Further analysis of muscle mRNA and gene expression in the presence of variants like splicing alterations. Material and methods: Eighty-six patients (38 female and 48 male) were referred for genetic evaluation because of variable clinical presentations ranging from asymptomatic hyper-CK-hemia to progressive proximal muscle weakness. Genetic analysis was performed with Whole Exome Sequencing (WES) or semi-targeted Exome Sequencing comprising ~4900 genes linked to known genetic disorders. Bioinformatic data analysis used SOPHiA DDM (Sophia Genetics) and VarAFT 2.14. software. Variants were classified according to the 2015 American College of Medical Genetics and Genomics (ACMG) criteria.In addition, six patients with a clinical diagnosis of muscular dystrophy and a positive muscle biopsy underwent RNA analysis with total mRNA extraction, reverse transcription and cDNA sequencing. Results: Causative variants were detected in 55 out of the 86 cases indicating a high diagnostic yield (63,95%). In total, 71 pathogenic/likely pathogenic variants were found in 25 genes linked to myopathies. Twenty two (31 %) were characterized as novel and four pathogenic copy number variations (CNV) were also detected. Most variants were missense (n=46, 65%), 8 were nonsense (11%), 8 frameshifts (11%) and only 2 variants were in frame (3%). In addition, 3 splice site pathogenic variants in 3 unrelated patients (4%) were disclosed. RNA analysis in 5/6 patients revealed alterations of splicing pathways whereby leading to more than one alternative transcripts. Discussion: In line with international efforts towards developing diagnostic algorithms for myopathies this study applied protocols to facilitate the diagnosis of complex and heterogeneous disorders, like the hereditary myopathies, in a large scale of Greek patients for the first time. Our results are considered to contribute significantly to the recognition of these disorders as well as provide evidence for genotype-phenotype correlation.

Degree

thesis:*
Grantor dc:publisher
National and Kapodistrian University of Athens
Year dc:date
2022

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Svingou, Maria
  • Σβίγγου, Μαρία

Subjects

dc:subject × 14

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/51744

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Svingou, Maria; Σβίγγου, Μαρία. Γενωμική διερεύνηση μη ταυτοποιημένων μυοπαθειών. National and Kapodistrian University of Athens, 2022. http://hdl.handle.net/10442/hedi/51744